Advancements in Translational Science for Pain Management in Cancer Care Symposium

---

LIVEPain MedicinePain Mgmt.Internal Medicine

Friday, May 10, 2024, 7:30 AM - 5:00 PM, MD Anderson - Zayed, Houston, TX


AMA PRA Category 1 Credits™ (5.75 hours), AAPA Category 1 CME (5.75 hours), ACPE Contact Hour(s) (5.75 hours), ANCC - Nursing Contact Hour(s) (5.75 hours), Non-Physician Attendance (5.75 hours)

The Advancements in Translational Science for Pain Management in Cancer Care Symposium: A Catalyst for Collaborative Innovation in Pain Sciences. This unique platform unites experts from diverse backgrounds, fostering interdisciplinary discussions on cutting-edge research. Bridging gaps between departments, the symposium stimulates new projects, aiming to advance the understanding and treatment of post-cancer pain. Breaking silos in pain research, it cultivates innovative solutions, shaping the future of pain management. Join us for a transformative event blending scientific exploration, collaborative networking, and the opportunity to shape the future of pain management.

Keynote Speaker

We are pleased to announce that Dr. Sean Mackey will be the keynote speaker for the May 10 symposium, Advancements in Translational Science for Pain Management in Cancer Care. Dr. Mackey’s extensive experience in the realm of pain research—including innovative work in pain assessment and strong ties to patient care in pain research and treatment—gives him new and unique insights that will be of interest to this diverse audience.

Dr. Mackey is Redlich Professor of Anesthesiology, Perioperative and Pain Medicine, Chief of the Division of Pain Medicine, and Director of the Stanford Systems Neuroscience and Pain Lab http://snapl.stanford.edu/ at Stanford University. He received his B.S.E. and M.S.E. in Bioengineering from the University of Pennsylvania and his Ph.D. in Electrical and Computer Engineering, as well as his M.D., from the University of Arizona. He completed his residency and pain medicine fellowship at Stanford and joined the faculty there in 1999.

Dr. Mackey has served as principal investigator on multiple NIH and FDA grants seeking to better understand the mechanisms of pain and to translate that knowledge into safe and effective therapies. He has authored more than 300 journal articles and book chapters, in addition to having co-authored the Institutes of Medicine’s report on Relieving Pain in America. He was Co-Chair of the HHS/NIH National Pain Strategy, an effort to establish a national health strategy for pain care, education, and research. 

 

1. Generate ideas and connections required to perform cutting-edge basic and translational research in order to develop novel assessment tools and treatments for pain management.
2. Develop methods to train the next generation of international thought leaders in pain research and care.
3. Utilize existing pain management assets within MD Anderson to improve the quality of care provided to patients.

The Advancements in Translational Science for Pain Management in Cancer Care Symposium, will take place in the Zayed Building (6565 MD Anderson Blvd), Floor 2, conference center. The symposium will begin at 8:00 AM on Friday, May 10, 2024 and the conference will conclude at 5:00 PM.

Advanced registration is encouraged as space is limited.  Please see registration section below for applicable fees. 

CONFERENCE REGISTRATION FEES	Before April 10, 2024	After April 10, 2024
MDACC: Physician (MD, DO)	$50.00	$65.00
MDACC: Healthcare Providers	$40.00	$55.00
Non-MDACC: Physician (MD, DO)	$80.00	$95.00
Non-MDACC: Healthcare Providers	$70.00	$85.00
Patients Caregiver	$25.00	$30.00
Researchers, Fellows, and Trainees	$40.00	$40.00

We accept the following forms of payment:

  •Credit Cards (MasterCard, VISA, and American Express)
  •Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
   Continuing Professional Education (CPE) – Unit 1781
   The University of Texas MD Anderson Cancer Center
   P.O. Box 301407
   Houston, Texas 77230-1407

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.  The Zoom ID and Password will be communicated via email 72 hours before the symposium start time. Video recording of the event will be available online for 30 days after the symposium. CME credit will not be awarded for viewing the video recordings.

Telephone registrations are not accepted.

Refund/Cancellation Policy
The registration fee, minus a $25 administration-handling fee, is refundable if a written request is received on or before April 10, 2024. No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form. In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

For additional information or Special Assistance, contact CPE at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected]

Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.  The survey link will be provided during the review course.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Texas MD Anderson Cancer Center designates this live activity will award 5.75 Nursing Contact Hour(s)

The University of Texas MD Anderson Cancer Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This application-based activity has been approved for 5.75 contact hours (5.75 CEU) under universal activity number UAN JA0004118-0000-23-002-L08-P.

 

 

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, May 10, 2024

Click Here to View Complete Exhibit Package Details

W9 Form